KRISTIN HICKMAN: Open Payments
NPI 1699328765 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 50 payments from 21 companies in 2025. Trend: 2023 $2,144 · 2024 $1,490 · 2025 $1,145
Food & beverage: $1,089Education: $56
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $155 |
| Pharming Healthcare, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Neurocrine BioSciences, Inc. | 4 | $77 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| CSL Behring | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| PFIZER INC. | 3 | $61 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $57 |
| SANOFI-AVENTIS U.S. LLC | 1 | $56 |
Products named: Ozempic, INGREZZA, DUPIXENT, Hizentra, REXULTI, NEFFY, NUCALA, XIFAXAN.
Industry payments across TN — which companies pay providers there.
